82 related articles for article (PubMed ID: 7909152)
1. Stromal tumors of the stomach: prognostic value of the PCNA index.
Ray R; Tahan SR; Andrews C; Goldman H
Mod Pathol; 1994 Jan; 7(1):26-30. PubMed ID: 7909152
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
3. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors.
Franquemont DW; Frierson HF
Mod Pathol; 1995 Jun; 8(5):473-7. PubMed ID: 7675763
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
6. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
[TBL] [Abstract][Full Text] [Related]
7. [New histopathologic data of prognostic value in extra-adrenal paragangliomas. Study of 9 cases].
García Rojo M; Martínez García C; Gamallo Amat C; Patrón Romero M
Med Clin (Barc); 1993 Sep; 101(9):327-32. PubMed ID: 8105157
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor.
Chen WT; Huang CJ; Wu MT; Yang SF; Su YC; Chai CY
Jpn J Clin Oncol; 2005 Apr; 35(4):207-13. PubMed ID: 15845570
[TBL] [Abstract][Full Text] [Related]
9. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
11. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome.
Reith JD; Goldblum JR; Lyles RH; Weiss SW
Mod Pathol; 2000 May; 13(5):577-85. PubMed ID: 10824931
[TBL] [Abstract][Full Text] [Related]
12. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors.
Vrettou E; Karkavelas G; Christoforidou B; Meditskou S; Papadimitriou CS
Anticancer Res; 1995; 15(3):943-9. PubMed ID: 7645984
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferative activity.
Ioachim E; Goussia A; Stefanou D; Agnantis NJ
Anticancer Res; 1997; 17(1A):513-7. PubMed ID: 9066704
[TBL] [Abstract][Full Text] [Related]
16. Expression of proliferating cell nuclear antigen(PCNA) in biopsy and autopsy specimens of gastric carcinoma.
He XB; Ii K; Muguruma N; Hayashi S; Ito S
J Med Invest; 1998 Feb; 44(3-4):149-53. PubMed ID: 9597802
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
[TBL] [Abstract][Full Text] [Related]
18. [Stromal tumors of the digestive tract. Prognostic evaluation of a series of 36 cases].
Ghnassia JP; Wagner M; Velten M
Ann Pathol; 1996; 16(1):27-32. PubMed ID: 8651997
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]